This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dory, D.
Right arrow Articles by Jestin, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dory, D.
Right arrow Articles by Jestin, A.

 Previous Article  |  Next Article 

Clinical and Vaccine Immunology, April 2007, p. 470-473, Vol. 14, No. 4
1071-412X/07/$08.00+0     doi:10.1128/CVI.00428-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Limited Protection Conferred by a DNA Vaccine against a Lethal Pseudorabies Virus Infection at Day 5 Postvaccination{triangledown}

Daniel Dory,1* Anne-Marie Torché,1 Véronique Béven,1 Roland Cariolet,2 and André Jestin1

Viral Genetics and Biosafety Unit, French Food Safety Agency (Afssa), Fr-22440 Ploufragan, France,1 Healthy Pigs Production and Experimentation Section, Afssa, Fr-22440 Ploufragan, France2

Received 16 November 2006/ Returned for modification 18 December 2006/ Accepted 1 February 2007

No pseudorabies virus (PRV)-specific neutralizing or immunoglobulin G1-type antibodies were detected in sera 5 days after injection of a DNA vaccine against PRV infection in pigs. PRV-stimulated peripheral blood mononuclear cells produced gamma interferon mRNA in vitro. Two out of five pigs recovered from lethal PRV infection without attenuation of nasal viral excretion.

* Corresponding author. Mailing address: Viral Genetics and Biosafety Unit, Afssa (French Food Safety Agency), BP-53, Fr-22440 Ploufragan, France. Phone: 00 33 2 96 01 64 42. Fax: 00 33 2 96 01 62 83. E-mail: d.dory{at}ploufragan.afssa.fr

{triangledown} Published ahead of print on 14 February 2007.

Clinical and Vaccine Immunology, April 2007, p. 470-473, Vol. 14, No. 4
1071-412X/07/$08.00+0     doi:10.1128/CVI.00428-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.





Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»